Arja Helin-Salmivaara, MD, PhD
Articles
February 5th 2010
Arja Helin-Salmivaara, MD, PhD Piia T. Lavikainen, MSc Maarit J. Korhonen, LicSc(Pharm), PhD(Epid) Heli Halava, MD Jaana E. Martikainen, LicSc(Pharm) Leena K. Saastamoinen, PhD(Pharm) Lauri Virta, MD, PhD Timo Klaukka, MD, PhD&dagger Risto Huupponen, MD, PhD
One-year persistence among new users of statins in Finland improved from 1995 to 1998, after which no substantial changes were observed up to 2004.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: November 21st 2024 | Updated: November 24th 2024
Polygenic Risk Scores Can Identify Patients Who Should Receive IOP-Lowering Treatment
